Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Immunitor at 3rd Virtual HIV/AIDS Congress


Immunitor at 3rd Virtual HIV/AIDS Congress to commemorate AIDS day

Immunitor Company announces presentation of a paper ‘Mucosal AIDS vaccines’ at the 3rd Virtual HIV/AIDS Congress which started on internet on October 14, 2002 and closed on World AIDS day on December 1, 2002.

The complete html or PDF version of the paper can be found at http://www.aidscongress.net/article.php?id_comunicacao=143.

The paper is presented in Basic Science section. Other topics covered at this Congress include: Social and Behavioral Science; Epidemiology, Prevention and Public Health; Clinical Science and Care; and HIV and Tuberculosis. This Congress is the third annual event organized by AIDSPortugal.com - the non-profit Portuguese association SIDAnet which unites medical professionals and social workers to provide treatment and counseling for people with AIDS.

The presented paper summarizes as to what is the best strategy for developing a potent AIDS vaccine since all feasible and obvious approaches in making AIDS vaccines have been tried in past two decades without much of success. The presentation draws attention to the fact that new thinking and revision of prevailing dogmas needs to be in place if we really want a vaccine. Conventional envelope-based antibody-inducing vaccines do not appear to hold a promise and cellular immune responses, especially those mediated by CD8 cytotoxic/suppressor (CTL) and CD4 helper T lymphocytes, seem to be needed to control HIV. Vaccines capable of inducing cell-mediated responses are, therefore, considered critical for controlling the spread of HIV. DNA-based vaccines are currently thought to be an answer but will they fulfill the promise? The review of state-of-the-art is provided to summarize what we know and still don’t know. The focus of the discussion is primarily on mucosal vaccines – relatively new area in AIDS research. The update on V-1 Immunitor, the oral AIDS vaccine produced in Thailand, is provided within this context. The paper ended with a conclusion that without departure from the uninspiring consensus no substantial progress in AIDS vaccine field can be envisioned.


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Mycoplasma Bovis: More Properties Positive

One of the latest infected properties is in the Hastings district, the other three are within a farming enterprise in Winton. The suspect property is near Ashburton. More>>

ALSO:

Manawatū Gorge Alternative: More Work Needed To Choose Route

“We are currently working closely and in partnership with local councils and other stakeholders to make the right long-term decision. It’s vital we have strong support on the new route as it will represent a very significant long-term investment and it will need to serve the region and the country for decades to come.” More>>

ALSO:

RBNZ: Super Fund Chief To Be New Reserve Bank Governor

Adrian Orr has been appointed as Reserve Bank Governor effective from 27 March 2018, Finance Minister Grant Robertson says. More>>

ALSO:

ScoopPro: Helping PR Professionals Get More Out Of Scoop

Scoop.co.nz has been a fixture of New Zealand’s news and Public Relations infrastructure for over 18 years. However, without the financial assistance of those using Scoop in a professional context in key sectors such as Public Relations and media, Scoop will not be able to continue this service... More>>

Insurance: 2017 Worst Year On Record For Weather-Related Losses

The Insurance Council of New Zealand (ICNZ) announced today that 2017 has been the most expensive year on record for weather-related losses, with a total insured-losses value of more than $242 million. More>>

ALSO: